XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.25.1

LOSS PER SHARE | 3 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
LOSS PER SHARE | LOSS PER SHARE Basic loss per share is computed by dividing loss available to common shareholders by the weighted average number of common shares outstanding for the period. In accordance with ASC 260, Penny Warrants are included in the calculation of weighted average basic and diluted loss per share for the period that they are classified as equity. For the three months ended March 31, 2025, 0.8 million Penny Warrants have been included in the calculation of weighted average basic and diluted loss per share. Diluted net loss per share excludes all dilutive securities because their impact would be anti-dilutive, as described below. Basic and diluted loss per share are calculated as follows:
|  |  |  | Three months ended March 31,
(in thousands, except per share data) |  |  |  |  |  | 2025 |  | 2024
Net loss attributable to Altisource |  |  |  |  |  | $ | (5,344) |  |  | $ | (9,198) |
Weighted average common shares outstanding, basic |  |  |  |  |  | 58,122 |  |  | 28,181 |
Weighted average common shares outstanding, diluted |  |  |  |  |  | 58,122 |  |  | 28,181 |
Loss per share: |  |  |  |  |  |  |  |
Basic |  |  |  |  |  | $ | (0.09) |  |  | $ | (0.33) |
Diluted |  |  |  |  |  | $ | (0.09) |  |  | $ | (0.33) |
For the three months ended March 31, 2025 and 2024, 5.3 million and 2.1 million, respectively, stock options, restricted shares and RSUs were excluded from the computation of loss per share, as a result of the following: •For the three months ended March 31, 2025 and 2024, 4.2 million and 0.7 million, respectively, stock options, restricted shares and RSUs were anti-dilutive and have been excluded from the computation of diluted loss per share because the Company incurred a net loss •For the three months ended March 31, 2025 and 2024, 0.2 million and 0.4 million, respectively, stock options were anti-dilutive and have been excluded from the computation of diluted loss per share because their exercise price was greater than the average market price of our common stock •For the three months ended March 31, 2025 and 2024, 0.9 million and 1.0 million, respectively, stock options, restricted shares and RSUs, which begin to vest upon the achievement of certain market criteria related to our common stock price, performance criteria and a total shareholder return compared to the market benchmark, have been excluded from the computation of diluted loss per share because the achievement levels have not yet been met •For the three months ended March 31, 2025, Stakeholder Warrants were anti-dilutive and have been excluded from the computation of diluted loss per share because their exercise price was greater than the average market price of our common stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration